Novanta/$NOVT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Novanta
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Ticker
$NOVT
Sector
Digital Hardware
Primary listing
Employees
3,000
Headquarters
Website
Novanta Metrics
BasicAdvanced
$3.8B
72.22
$1.46
1.59
-
Price and volume
Market cap
$3.8B
Beta
1.59
52-week high
$179.87
52-week low
$98.76
Average daily volume
633K
Financial strength
Current ratio
2.507
Quick ratio
1.39
Long term debt to equity
60.966
Total debt to equity
63.044
Interest coverage (TTM)
4.98%
Profitability
EBITDA (TTM)
180.487
Gross margin (TTM)
45.09%
Net profit margin (TTM)
5.50%
Operating margin (TTM)
12.63%
Effective tax rate (TTM)
23.18%
Revenue per employee (TTM)
$320,000
Management effectiveness
Return on assets (TTM)
5.18%
Return on equity (TTM)
6.84%
Valuation
Price to earnings (TTM)
72.219
Price to revenue (TTM)
3.953
Price to book
4.72
Price to tangible book (TTM)
-96.22
Price to free cash flow (TTM)
36.995
Free cash flow yield (TTM)
2.70%
Free cash flow per share (TTM)
2.85
Growth
Revenue change (TTM)
4.07%
Earnings per share change (TTM)
-12.05%
3-year revenue growth (CAGR)
4.50%
10-year revenue growth (CAGR)
9.79%
3-year earnings per share growth (CAGR)
-10.40%
10-year earnings per share growth (CAGR)
46.91%
What the Analysts think about Novanta
Analyst ratings (Buy, Hold, Sell) for Novanta stock.
Bulls say / Bears say
Analysts maintain a “buy” consensus with a median 12-month price target of $158.50, suggesting about 22.4% upside from the last closing price (Reuters).
Management’s approval of an additional $200 million share repurchase program on September 18, 2025 signals confidence in the company’s cash flow and commitment to shareholder returns (CNBC).
Second-quarter revenue is projected to rise about 0.9% year over year to $237.99 million, highlighting steady top-line growth in its main markets (Reuters).
Stock is down about 32.7% year-to-date, lagging behind broader tech and medical equipment indices, signaling investor concerns over future growth (CNBC).
The resignation of board member Barbara Hulit on September 18, 2025 may create uncertainty around the company’s governance and disrupt its strategic direction (CNBC).
Second-quarter guidance for gross profit margins of 45.5%–46.5% indicates possible margin pressure compared to historical levels, which could point to weaker pricing power or higher costs (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 3 Nov 2025.
Novanta Financial Performance
Revenues and expenses
Novanta Earnings Performance
Company profitability
Novanta News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novanta stock?
Novanta (NOVT) has a market cap of $3.8B as of November 09, 2025.
What is the P/E ratio for Novanta stock?
The price to earnings (P/E) ratio for Novanta (NOVT) stock is 72.22 as of November 09, 2025.
Does Novanta stock pay dividends?
No, Novanta (NOVT) stock does not pay dividends to its shareholders as of November 09, 2025.
When is the next Novanta dividend payment date?
Novanta (NOVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Novanta?
Novanta (NOVT) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.